NasdaqGS:CLBTSoftware
A Look At Cellebrite DI (CLBT) Valuation After 2026 Guidance And Forensics Acquisitions
Cellebrite DI (NasdaqGS:CLBT) drew fresh attention after reporting 2025 results and issuing 2026 guidance that points to higher annual recurring revenue, improved profitability, and continued cloud adoption, alongside acquisitions in Corellium and SCG Canada.
See our latest analysis for Cellebrite DI.
The latest guidance and acquisition news land after a choppy spell for the stock, with a 30 day share price return of 24% decline and a 1 year total shareholder return of 36.9% decline. However,...